Ethical Issues in Neuroscience and Neuropsychiatric: A Review of Major Issues

Adji Suwandono, Graffico Eryza Oldiara, Fitri Pranita Milyarona

Abstract


Adherence to ethical principles is essential nowadays in neuroscience and neuropsychiatric research. observance of ethical principles is essential in the case of neurology and neuroscience research, as it is in all the other medical and surgical fields. as neuroscience research advances, researchers, clinicians, and other stakeholders will face a host of ethical challenges. Ethical problems of neuroscience-based diagnosis and interventions. This section concerns problems resulting from neuroimaging, pharmacological brain enhancement, and new technical interventions in the brain. The research is based on a literature review, so data will be collected from literary sources such as scientific journals, books, and articles in January 2023 relating to the research topic. The literature search process must be systematically documented, including keywords, databases used, and search dates. Data analysis will be carried out by reading and understanding the content of the literature, identifying ethical problems encountered in the field of neuroscience and neuropsychiatry, and analyzing different perspectives in addressing these ethical problems.  In this article, we also review the major ethical issues raised by advances in neuropsychiatric genetics. Advances in neuroscience raise ethical, social, and legal issues about the human person and the brain. The potential benefits of applying neuroimaging, psychopharmacology, and neurotechnology to support mentally ill and healthy persons have to be carefully weighed against their potential harm. Questions concerning underlying concepts of humans should be actively dealt with by interdisciplinary and public debate.  t is therefore essential to develop bioethics and encourage discoveries in neuroscience to firmly respect the ethical principles available at the time of their publication.


Keyword: Ethical Issues, Neuroscience, Neuropsychiatric

Full Text:

PDF

References


Amadio, J., Bi, G.-Q., Boshears, P. F., Carter, A., Devor, A., Doya, K., Garden, H., Illes, J., Johnson, L. S. M., & Jorgenson, L. (2018). Neuroethics questions to guide ethical research in the international brain initiatives. Neuron, 100(1), 19–36.

Blake, V. (2012). When is a patient-physician relationship established? Virtual Mentor, 14(5), 403–406. https://doi.org/10.1001/virtualmentor.2012.14.5.hlaw1-1205

Borah, B. R., Strand, N. K., & Chillag, K. L. (2016). Advancing ethical neuroscience research. AMA Journal of Ethics, 18(12), 1192–1198.

Decety, J., & Moriguchi, Y. (2007). The empathic brain and its dysfunction in psychiatric populations: Implications for intervention across different clinical conditions. BioPsychoSocial Medicine, 1, 1–21. https://doi.org/10.1186/1751-0759-1-22

EISEMAN, E. (2003). Contributing to Public Policy. RAND, https://www. rand. org/pubs/monograph_reports/MR1546.

Fuchs, T. (2006). Ethical issues in neuroscience. [Miscellaneous]. Current Opinion in Psychiatry, 19(6), 600–607. http://www.antoniocasella.eu/dnlaw/Fuchs_2006.pdf

Fulda, K. G., & Lykens, K. (2006). Ethical issues in predictive genetic testing: A public health perspective. Journal of Medical Ethics, 32(3), 143–147. https://doi.org/10.1136/jme.2004.010272

Hoge, S. K., & Appelbaum, P. S. (2012). Ethics and neuropsychiatric genetics: A review of major issues. International Journal of Neuropsychopharmacology, 15(10), 1547–1557. https://doi.org/10.1017/S1461145711001982

Israel, M. (2014). Research ethics and integrity for social scientists: Beyond regulatory compliance. Sage.

Lakhan, S. E., & Kirchgessner, A. (2012). Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: Misuse, cognitive impact, and adverse effects. Brain and Behavior, 2(5), 661–677. https://doi.org/10.1002/brb3.78

Lucassen, A., & Gilbar, R. (2018). Alerting relatives about heritable risks: the limits of confidentiality. BMJ, 5(April), 361: k1409. https://doi.org/doi: 10.1136/bmj.k1409

Nakagawa, T. A., Ashwal, S., Mathur, M., Mysore, M., & Society of Critical Care Medicine and the Child Neurology Society, S. on C. C. and S. on N. of the A. A. of P. (2011). Guidelines for the determination of brain death in infants and children: an update of the 1987 Task Force recommendations. In Pediatrics (Vol. 128, Issue 3, pp. e720–e740). American Academy of Pediatrics Elk Grove Village, IL, USA.

Nestor, J., Borah, B. R., Strand, N. K., Chillag, K. L., Choudhury, S., Moore, S., Preston, J., McTeigue, J., Opperman, C., & Dean, J. (2016). AMA Journal of Ethics®. Ethics, 18(12), 1165–1252.

O’Connell, K. S., & Coombes, B. J. (2021). Genetic contributions to bipolar disorder: Current status and future directions. Psychological Medicine, 51(13), 2156–2167. https://doi.org/10.1017/S0033291721001252

Oates, J., & Lopez, D. (2018). Pharmacogenetics: An Important Part of Drug Development with A Focus on Its Application. International Journal of Biomedical Investigation, 1(2), 1–16. https://doi.org/10.31531/2581-4745.1000111

Paradise, J. (2013). Funding, and Ethics, for the BRAIN Initiative. Health Reform Watch, October.

Rollinson, V., Turner, R., & Pirmohamed, M. (2020). Pharmacogenomics for primary care: An overview. Genes, 11(11), 1–29. https://doi.org/10.3390/genes11111337

Rossi, S., Hallett, M., Rossini, P. M., Pascual-Leone, A., & Group, S. of T. M. S. C. (2009). Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology, 120(12), 2008–2039.

Silumbwe, A., Nkole, T., Munakampe, M. N., Milford, C., Cordero, J. P., Kriel, Y., Zulu, J. M., & Steyn, P. S. (2018). Community and health systems barriers and enablers to family planning and contraceptive services provision and use in Kabwe District, Zambia. BMC Health Services Research, 18(1), 1–11. https://doi.org/10.1186/s12913-018-3136-4

Staudt, M. D., Herring, E. Z., Gao, K., Miller, J. P., & Sweet, J. A. (2019). Evolution in the treatment of psychiatric disorders: From psychosurgery to psychopharmacology to neuromodulation. Frontiers in Neuroscience, 13(FEB), 1–10. https://doi.org/10.3389/fnins.2019.00108

Widitia, R., Entianopa, & Hapis, A. A. (2020). Faktor Yang Berhubungan Dengan Keluhan Muskuloskeletal Pada Pekerja di PT. X Tahun 2019. Contagion :Scientific Periodical of Public Health and Coastal Health2, 2(2), 76–86. https://doi.org/http://dx.doi.org/10.30829/contagion.v2i2.7241




DOI: http://dx.doi.org/10.30829/contagion.v5i2.14934

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Adji Suwandono, Graffico Eryza Oldiara, Fitri Pranita Milyarona

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 
Contagion: Scientific Periodical Journal of Public Health and Coastal Health by Program Studi Ilmu Kesehatan Masyarakat is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.